FDA Issues Guidance On Biotech Pharmaceutical Testing
The nonbinding recommendations, which update standards issued in the 1990s, relate to a long-standing effort at harmonizing clinical development taking place in the U.S., Europe and Japan.
Topics include proper selection of animal species for pharmaceutical testing, design of preclinical studies, measurement of immune system response, evaluation of cancer risks and screening of effects on...
Already a subscriber? Click here to login